Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.

Saved in:
Bibliographic Details
Title: Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.
Authors: Rowe CL; Division of Epidemiology, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA; Center on Substance Use and Health, San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA. Electronic address: chrisrowe@berkeley.edu., Ahern J; Division of Epidemiology, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA., Hubbard A; Division of Biostatistics, School of Public Health, University of California, Berkeley, 2121 Berkeley Way, Floor 5, Berkeley, CA 94704, USA., Coffin PO; Center on Substance Use and Health, San Francisco Department of Public Health, 25 Van Ness, Suite 500, San Francisco, CA 94102, USA; Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, 533 Parnassus Ave, San Francisco, CA 94143, USA.
Source: Journal of substance abuse treatment [J Subst Abuse Treat] 2022 Jan; Vol. 132, pp. 108452. Date of Electronic Publication: 2021 Apr 30.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Pergamon Press Country of Publication: United States NLM ID: 8500909 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6483 (Electronic) Linking ISSN: 07405472 NLM ISO Abbreviation: J Subst Abuse Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-6483
DOI:10.1016/j.jsat.2021.108452